The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 4,542 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 00653A107 | 326 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| AFFIMED NV | COM | N01045108 | 1,476 | 595,000 | SH | SOLE | 595,000 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS | COM | 00847X104 | 3,561 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
| AMAG PHARMACEUTICALS INC | COM | 00163U106 | 2,870 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 3,802 | 1,760,000 | SH | SOLE | 1,760,000 | 0 | 0 | ||
| AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 1,953 | 295,000 | SH | SOLE | 295,000 | 0 | 0 | ||
| ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 9,238 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
| AURIS MED HLDG AG | COM | H03579101 | 1,425 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | ||
| AXOGEN INC | COM | 05463X106 | 14,586 | 2,120,000 | SH | SOLE | 2,120,000 | 0 | 0 | ||
| BIOLINERX LTD | SPONSORED ADR | 09071M106 | 223 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 5,063 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| CARA THERAPEUTICS INC | COM | 140755109 | 4,016 | 835,000 | SH | SOLE | 835,000 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 2,653 | 675,000 | SH | SOLE | 675,000 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 443 | 43,000 | SH | SOLE | 43,000 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 4,749 | 1,178,500 | SH | SOLE | 1,178,500 | 0 | 0 | ||
| CORIUM INTL INC | COM | 21887L107 | 1,249 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
| CYNAPSUS THERAPEUTICS INC | COM PAR NO PAR | 23257Y859 | 2,094 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | 1,634 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
| EAGLE PHARMACEUTICALS INC | COM | 269796108 | 1,940 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| EDGE THERAPEUTICS INC | COM | 279870109 | 2,281 | 225,600 | SH | SOLE | 225,600 | 0 | 0 | ||
| EVOKE PHARMA INC | COM | 30049G104 | 891 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 5,415 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | ||
| FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 4,413 | 695,000 | SH | SOLE | 695,000 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 2,522 | 152,000 | SH | SOLE | 152,000 | 0 | 0 | ||
| HORIZON PHARMA PLC | COM | G4617B105 | 3,294 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 3,016 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
| IMPRIMIS PHARMACEUTICALS INC | COM NEW | 45323A201 | 4,766 | 1,267,500 | SH | SOLE | 1,267,500 | 0 | 0 | ||
| INNOCOLL HOLDINGS PLC | SHS | G4783X105 | 1,460 | 265,000 | SH | SOLE | 265,000 | 0 | 0 | ||
| INOTEK PHARMACEUTICALS CORP | COM | 45780VAA0 | 4,799 | 645,000 | SH | SOLE | 645,000 | 0 | 0 | ||
| INTEC PHARMA LTD JERUSALEM | SHS | M53644106 | 2,989 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| LION BIOTECHNOLOGIES INC | COM | 53619R102 | 2,106 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 3,023 | 112,000 | SH | SOLE | 112,000 | 0 | 0 | ||
| MEDGENICS INC | COM NEW | 58436Q203 | 10,823 | 1,950,000 | SH | SOLE | 1,950,000 | 0 | 0 | ||
| NABRIVA THERAPEUTICS AG | SPONSORED ADR | 62957M104 | 2,025 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | ||
| NEURODERM LTD | ORD SHS | M74231107 | 853 | 52,500 | SH | SOLE | 52,500 | 0 | 0 | ||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 1,287 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
| PARATEK PHARMACEUTICALS INC | COM | 699374302 | 2,041 | 146,700 | SH | SOLE | 146,700 | 0 | 0 | ||
| PROTALIX BIOTHERAPEUTICS INC | COM | 74365AAB7 | 5,248 | 8,200,000 | SH | SOLE | 8,200,000 | 0 | 0 | ||
| PROTEOSTASIS THERAPEUTICS IN | COM | 74373B109 | 1,274 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
| SERES THERAPEUTICS INC | COM | 81750R102 | 1,670 | 57,500 | SH | SOLE | 57,500 | 0 | 0 | ||
| SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 2,546 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| TENAX THERAPEUTICS INC | COM | 88032L100 | 1,190 | 465,000 | SH | SOLE | 465,000 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 1,061 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| TONIX PHARMACEUTICALS HLDG C | COM NEW | 890260201 | 1,592 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 1,751 | 195,000 | SH | SOLE | 195,000 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 3,179 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 2,419 | 410,000 | SH | SOLE | 410,000 | 0 | 0 | ||
| ZOGENIX INC | COM NEW | 98978L105 | 1,932 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | ||